# OPDIVO QVANTIG

NDC: 0003-6120
Generic name: nivolumab and hyaluronidase-nvhy
Labeler / Manufacturer: E.R. Squibb & Sons, L.L.C.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20250102

FDA application: BLA761381

## Active ingredients

- HYALURONIDASE (HUMAN RECOMBINANT): 2000 U/mL
- NIVOLUMAB: 120 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0003-6120"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0003-6120
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f8c38fa-42f4-4387-9e8c-7a1c66855d8b